![3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same](/docs/US/2022-04-05/US11292794B2/abs.jpg.600x600.jpg)
- 专利标题： 3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same
-
申请号： US16791715申请日： 2020-02-14
-
公开(公告)号： US11292794B2公开(公告)日： 2022-04-05
- 发明人: Hiroyuki Kouji , Kentaro Yamada , Akira Katoh , Toshimasa Ishizaki , Shigeru Matsuoka , Akira Nishizono , Tadashi Mishina , Atsushi Yoshimori
- 申请人： Oita University Institute of Advanced Medicine, Inc.
- 申请人地址： JP Oita
- 专利权人： Oita University Institute of Advanced Medicine, Inc.
- 当前专利权人： Oita University Institute of Advanced Medicine, Inc.
- 当前专利权人地址： JP Oita
- 代理机构： Seed IP Law Group LLP
- 优先权： JPJP2018-153227 20180816
- 主分类号： C07D471/08
- IPC分类号： C07D471/08 ; C07D471/18 ; A61P31/14 ; A61P35/00
![3,6-methano-1H-pyrrolo[3,2-b]pyridine and 3,6-methano-1H-pyrrolo[3,2-C]pyridine compounds and medicaments using same](/abs-image/US/2022/04/05/US11292794B2/abs.jpg.150x150.jpg)
摘要：
The present disclosure provides a compound that is useful for the treatment and prophylaxis of rabies. The present disclosure provides a compound represented by formula XXIF or formula XXIB: wherein R1, R2A, R2B, R3, and R4 are defined in the specification, a solvent, or a pharmaceutically acceptable salt thereof, use of such a compound, solvate, or pharmaceutically acceptable salt thereof for the treatment or prophylaxis of rabies and cancer, a pharmaceutical composition comprising such a compound, solvate, or pharmaceutically acceptable salt thereof, and a method for the treatment or prophylaxis of rabies and cancer using the same.
公开/授权文献
- US20210214356A1 COMPOUNDS AND MEDICAMENTS USING SAME 公开/授权日：2021-07-15
信息查询
